General Information of Drug Off-Target (DOT) (ID: OTC427QQ)

DOT Name Protein fuzzy homolog (FUZ)
Gene Name FUZ
Related Disease
Neoplasm ( )
Androgen insensitivity syndrome ( )
Anencephaly ( )
Autism spectrum disorder ( )
Benign prostatic hyperplasia ( )
Helminth infection ( )
Hermansky-Pudlak syndrome ( )
Hydrocephalus ( )
Non-small-cell lung cancer ( )
Obesity ( )
Schistosomiasis ( )
Hyperparathyroidism 2 with jaw tumors ( )
Tuberous sclerosis ( )
Ebola virus infection ( )
Neural tube defects, susceptibility to ( )
Tardive dyskinesia ( )
UniProt ID
FUZZY_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
7Q3D
Pfam ID
PF19036 ; PF19037 ; PF19038
Sequence
MGEEGTGGTVHLLCLAASSGVPLFCRSSRGGAPARQQLPFSVIGSLNGVHMFGQNLEVQL
SSARTENTTVVWKSFHDSITLIVLSSEVGISELRLERLLQMVFGAMVLLVGLEELTNIRN
VERLKKDLRASYCLIDSFLGDSELIGDLTQCVDCVIPPEGSLLQEALSGFAEAAGTTFVS
LVVSGRVVAATEGWWRLGTPEAVLLPWLVGSLPPQTARDYPVYLPHGSPTVPHRLLTLTL
LPSLELCLLCGPSPPLSQLYPQLLERWWQPLLDPLRACLPLGPRALPSGFPLHTDILGLL
LLHLELKRCLFTVEPLGDKEPSPEQRRRLLRNFYTLVTSTHFPPEPGPPEKTEDEVYQAQ
LPRACYLVLGTEEPGTGVRLVALQLGLRRLLLLLSPQSPTHGLRSLATHTLHALTPLL
Function
Probable planar cell polarity effector involved in cilium biogenesis. May regulate protein and membrane transport to the cilium. Proposed to function as core component of the CPLANE (ciliogenesis and planar polarity effectors) complex involved in the recruitment of peripheral IFT-A proteins to basal bodies. May regulate the morphogenesis of hair follicles which depends on functional primary cilia.
Reactome Pathway
Hedgehog 'off' state (R-HSA-5610787 )

Molecular Interaction Atlas (MIA) of This DOT

16 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Neoplasm DISZKGEW Definitive Biomarker [1]
Androgen insensitivity syndrome DISUZBBO Strong Biomarker [2]
Anencephaly DISIYW6T Strong Genetic Variation [3]
Autism spectrum disorder DISXK8NV Strong Biomarker [4]
Benign prostatic hyperplasia DISI3CW2 Strong Altered Expression [5]
Helminth infection DIS7CGKY Strong Biomarker [6]
Hermansky-Pudlak syndrome DISCY0HQ Strong Biomarker [7]
Hydrocephalus DISIZUF7 Strong Genetic Variation [8]
Non-small-cell lung cancer DIS5Y6R9 Strong Altered Expression [9]
Obesity DIS47Y1K Strong Biomarker [10]
Schistosomiasis DIS6PD44 Strong Biomarker [11]
Hyperparathyroidism 2 with jaw tumors DISWEGI1 moderate Genetic Variation [12]
Tuberous sclerosis DISEMUGZ moderate Genetic Variation [13]
Ebola virus infection DISJAVM1 Limited Biomarker [14]
Neural tube defects, susceptibility to DISHA84K Limited Unknown [15]
Tardive dyskinesia DISKA5RC Limited Genetic Variation [16]
------------------------------------------------------------------------------------
⏷ Show the Full List of 16 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
5 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate affects the expression of Protein fuzzy homolog (FUZ). [17]
Tretinoin DM49DUI Approved Tretinoin decreases the expression of Protein fuzzy homolog (FUZ). [18]
Estradiol DMUNTE3 Approved Estradiol decreases the expression of Protein fuzzy homolog (FUZ). [19]
Amiodarone DMUTEX3 Phase 2/3 Trial Amiodarone increases the expression of Protein fuzzy homolog (FUZ). [20]
Bisphenol A DM2ZLD7 Investigative Bisphenol A decreases the expression of Protein fuzzy homolog (FUZ). [22]
------------------------------------------------------------------------------------
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the methylation of Protein fuzzy homolog (FUZ). [21]
------------------------------------------------------------------------------------

References

1 Myricetin exerts anti-proliferative, anti-invasive, and pro-apoptotic effects on esophageal carcinoma EC9706 and KYSE30 cells via RSK2.Tumour Biol. 2014 Dec;35(12):12583-92. doi: 10.1007/s13277-014-2579-4. Epub 2014 Sep 6.
2 Promoter-dependent activity on androgen receptor N-terminal domain mutations in androgen insensitivity syndrome.Sex Dev. 2014;8(6):339-49. doi: 10.1159/000369266. Epub 2014 Dec 6.
3 Glutamate carboxypeptidase II gene polymorphisms and neural tube defects in a high-risk Chinese population.Metab Brain Dis. 2012 Mar;27(1):59-65. doi: 10.1007/s11011-011-9272-8. Epub 2011 Nov 29.
4 Does high-dose gestational folic acid increase the risk for autism? The birth order hypothesis.Med Hypotheses. 2019 Nov;132:109350. doi: 10.1016/j.mehy.2019.109350. Epub 2019 Jul 31.
5 Androgen receptor isoforms expression in benign prostatic hyperplasia and primary prostate cancer.PLoS One. 2018 Jul 20;13(7):e0200613. doi: 10.1371/journal.pone.0200613. eCollection 2018.
6 Initiating NTD programs targeting schistosomiasis and soil-transmitted helminthiasis in two provinces of the Democratic Republic of the Congo: Establishment of baseline prevalence for mass drug administration.Acta Trop. 2017 Feb;166:177-185. doi: 10.1016/j.actatropica.2016.11.023. Epub 2016 Nov 22.
7 Hexa-Longin domain scaffolds for inter-Rab signalling.Bioinformatics. 2020 Feb 15;36(4):990-993. doi: 10.1093/bioinformatics/btz739.
8 "Isolated" hydrocephalus in families of spina bifida and anencephaly: a coincidence?.Neuropediatrics. 1989 Nov;20(4):220-2. doi: 10.1055/s-2008-1071297.
9 In vitro study of FUZ as a novel potential therapeutic target in non-small-cell lung cancer.Life Sci. 2018 Mar 15;197:91-100. doi: 10.1016/j.lfs.2018.02.007. Epub 2018 Feb 6.
10 Uncoupling protein 2 polymorphisms as risk factors for NTDs.Birth Defects Res A Clin Mol Teratol. 2009 Feb;85(2):156-60. doi: 10.1002/bdra.20520.
11 Schistosomiasis is more prevalent than previously thought: what does it mean for public health goals, policies, strategies, guidelines and intervention programs?.Infect Dis Poverty. 2017 Mar 22;6(1):63. doi: 10.1186/s40249-017-0275-5.
12 Crystal structure of the N-terminal domain of human CDC73 and its implications for the hyperparathyroidism-jaw tumor (HPT-JT) syndrome.Sci Rep. 2017 Nov 15;7(1):15638. doi: 10.1038/s41598-017-15715-9.
13 Crystal structure of the yeast TSC1 core domain and implications for tuberous sclerosis pathological mutations.Nat Commun. 2013;4:2135. doi: 10.1038/ncomms3135.
14 Commentary: restarting NTD programme activities after the Ebola outbreak in Liberia.Infect Dis Poverty. 2017 May 1;6(1):52. doi: 10.1186/s40249-017-0272-8.
15 Mutations in the planar cell polarity gene, Fuzzy, are associated with neural tube defects in humans. Hum Mol Genet. 2011 Nov 15;20(22):4324-33. doi: 10.1093/hmg/ddr359. Epub 2011 Aug 12.
16 Resting-state Brain Activity Changes Associated with Tardive Dyskinesia in Patients with Schizophrenia: Fractional Amplitude of Low-frequency Fluctuation Decreased in the Occipital Lobe.Neuroscience. 2018 Aug 10;385:237-245. doi: 10.1016/j.neuroscience.2018.06.014. Epub 2018 Jun 20.
17 Gene Expression Regulation and Pathway Analysis After Valproic Acid and Carbamazepine Exposure in a Human Embryonic Stem Cell-Based Neurodevelopmental Toxicity Assay. Toxicol Sci. 2015 Aug;146(2):311-20. doi: 10.1093/toxsci/kfv094. Epub 2015 May 15.
18 Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling. PLoS One. 2013 May 28;8(5):e63862.
19 17-Estradiol Activates HSF1 via MAPK Signaling in ER-Positive Breast Cancer Cells. Cancers (Basel). 2019 Oct 11;11(10):1533. doi: 10.3390/cancers11101533.
20 Identification by automated screening of a small molecule that selectively eliminates neural stem cells derived from hESCs but not dopamine neurons. PLoS One. 2009 Sep 23;4(9):e7155.
21 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
22 Bisphenol A Exposure Changes the Transcriptomic and Proteomic Dynamics of Human Retinoblastoma Y79 Cells. Genes (Basel). 2021 Feb 11;12(2):264. doi: 10.3390/genes12020264.